Document is current
Any future updates will be listed below
-
Authors
Al-Rifai, Rida
Nguyen, Philippe
Bouland, Nicole
Terryn, Christine
Kanagaratnam, Lukshe
Poitevin, Gaël
François, Caroline
Boisson-Vidal, Catherine
Sevestre, Marie-Antoinette
Tournois, Claire http://orcid.org/0000-0002-9946-837X
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct00533104 at ClinicalTrials.govDocuments that mention this clinical trial
In vivo efficacy of endothelial growth medium stimulated mesenchymal stem cells derived from patients with critical limb ischemia
https://doi.org/10.1186/s12967-019-2003-3
- License Information
-
More Information
Article History
Received: 18 November 2018
Accepted: 27 July 2019
First Online: 9 August 2019
Ethics approval and consent to participate
: The Bone Marrow Autograft in Limb Ischemia (BALI) protocol was approved by the French National Agency for Medicines and Health Products Safety and by an Institutional Review Board. The trial was registered on ExternalRef removed (identifier NCT00904501). Registered May 19, 2009, Study ID Numbers: PHRC2007-N11-02. Animal protocols were approved by the C2EA-56 (ethics committee in animal experimentation of Reims Champagne Ardenne, authorization number 4289-2016022217565171_v2).
: Patients were eligible for the BALI trial if they were ≥ 18 years of age. All patients admitted to the hospital where the study was carried out sign a written informed consent for use of their data for research purposes, as approved by the institutional Ethics Committee.
: The authors declare that they have no competing interests.
